Development of Medical Technology for Contingency Response to Marrow Toxic Agents
Abstract
The main objective of this grant is to develop, test and mature the ability of the National Marrow Donor Program (NMDP) to address contingency events wherein civilian or military personnel are exposed to marrow toxic agents, primarily ionizing radiation or chemical weapons containing nitrogen mustard. NMDPs on-going immunobiologic and clinical research, performed in close collaboration with independent investigators from nearly all U.S. academic medical centers, promote studies to advance the science and technology of hematopoietic cell transplantation (HCT) to improve outcomes and quality of life for patients. The Office of Naval Research funding plays key roles in advancing the success of HCT and the large number of innovative treatment approaches leading to continual improvements that make possible development of optimal care plans for potential casualties. An accident, a military incident, or terrorist act in which a number of individuals are exposed to marrow toxic agents will result in injuries from mild to lethal. Casualties will be triaged by first responders, and those with major marrow injuries who may ultimately be candidates for HCT will need to be identified. HCT donor identification activities will be initiated for all potential HCT candidates. NMDP-approved transplant centers will provide a uniform and consistent clinical foundation for receiving, evaluating and caring for casualties. NMDP coordinating center will orchestrate the process to rapidly identify the best available donor or cord blood unit for each patient utilizing its state-of-the-art communication infrastructure, sample repository, laboratory network, and human leukocyte antigen (HLA) expertise.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 07, 2016
- Accession Number
- AD1020758
Entities
People
- Stephen R. Spellman
Organizations
- National Marrow Donor Program